AMPX vs. MVST, BYRN, VCSA, HAO, VERI, EXFY, ZTEK, CCRD, SKYX, and ALOT
Should you be buying Amprius Technologies stock or one of its competitors? The main competitors of Amprius Technologies include Microvast (MVST), Byrna Technologies (BYRN), Vacasa (VCSA), Haoxi Health Technology (HAO), Veritone (VERI), Expensify (EXFY), Zentek (ZTEK), CoreCard (CCRD), SKYX Platforms (SKYX), and AstroNova (ALOT). These companies are all part of the "business services" sector.
Amprius Technologies (NYSE:AMPX) and Microvast (NASDAQ:MVST) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, community ranking, media sentiment, institutional ownership, dividends, valuation and risk.
Amprius Technologies has higher earnings, but lower revenue than Microvast. Amprius Technologies is trading at a lower price-to-earnings ratio than Microvast, indicating that it is currently the more affordable of the two stocks.
Amprius Technologies has a beta of 2.96, meaning that its stock price is 196% more volatile than the S&P 500. Comparatively, Microvast has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500.
5.0% of Amprius Technologies shares are owned by institutional investors. Comparatively, 20.7% of Microvast shares are owned by institutional investors. 14.9% of Amprius Technologies shares are owned by insiders. Comparatively, 31.3% of Microvast shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
In the previous week, Amprius Technologies had 11 more articles in the media than Microvast. MarketBeat recorded 16 mentions for Amprius Technologies and 5 mentions for Microvast. Microvast's average media sentiment score of 1.02 beat Amprius Technologies' score of 0.12 indicating that Microvast is being referred to more favorably in the news media.
Amprius Technologies presently has a consensus price target of $10.00, suggesting a potential upside of 629.93%. Microvast has a consensus price target of $4.50, suggesting a potential upside of 994.36%. Given Microvast's higher possible upside, analysts clearly believe Microvast is more favorable than Amprius Technologies.
Microvast has a net margin of -29.79% compared to Amprius Technologies' net margin of -350.70%. Microvast's return on equity of -18.01% beat Amprius Technologies' return on equity.
Amprius Technologies received 6 more outperform votes than Microvast when rated by MarketBeat users. Likewise, 94.12% of users gave Amprius Technologies an outperform vote while only 41.67% of users gave Microvast an outperform vote.
Summary
Microvast beats Amprius Technologies on 10 of the 18 factors compared between the two stocks.
Get Amprius Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMPX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMPX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Amprius Technologies Competitors List
Related Companies and Tools
